6 completed, 1 withdrawn. 3 Phase 1, 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
| Not applicable | 1 | Withdrawn 1 |
Follow ERB 041: new trials by email Literature Review of ERB 041 trials Research Report on ERB 041
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis ERB-041 - Cystitis, Interstitial | Not applicable | Withdrawn | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-08-01 | 2020-10-01 | |
| Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects ERB-041 - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 24 | 2006-08-01 | 2009-07-10 |
| Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women ERB-041 - Dysmenorrhea, Dyspareunia | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 150 | 2006-05-01 | 2007-12-10 |
| Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects ERB-041 - Healthy, Long QT Syndrome | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 64 | 2006-05-01 | 2007-04-13 |
| Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis Methotrexate plus ERB-041 for 12 weeks, Placebo for 12 weeks - Rheumatoid Arthritis | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 159 | 2005-08-01 | 2020-09-29 |
| Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women ERB-041 - Endometriosis | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 200 | 2005-01-01 | 2015-05-01 |
| Study Evaluating ERB-041 in Active Crohn's Disease ERB-041 - Crohn's Disease | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 22 | 2004-04-01 | 2009-09-10 |
Endometriosis (2) · Arthritis, Rheumatoid (1) · Crohn Disease (1) · Cystitis (1) · Cystitis, Interstitial (1) · Dysmenorrhea (1) · Dyspareunia (1) · Inflammation (1) · Long QT Syndrome (1) · Pelvic Pain (1)
Wyeth is now a wholly owned subsidiary of Pfizer (7)
United States (5) · Canada (2) · Australia (1) · Austria (1) · Belgium (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Italy (1) · Japan (1) · Mexico (1) · South Africa (1) · Spain (1) · United Kingdom (1)
2005 (1)